Gal-9 roles have been examined in different types of lung cancers, including non-small cell lung cancer (NSCLC) [188], small cell lung cancer (SCLC) [189], lung large cell neuroendocrine carcinoma (LCNEC) [190], and pulmonary sarcomatoid carcinoma (PSC) [191]. This evidence concerns the gene LGALS9 and lung carcinoma.